Has Novo Nordisk Finally Found the Catalyst That Could Flip the Script on Eli Lilly?
Novo Nordisk (NYSE: NVO) started the GLP-1 weight-loss revolution that is sweeping the world. Its Wegovy/Ozempic shot was…
Sun Pharma Requires High Court Approval for Semaglutide Tablet Launch Amid Patent Dispute, ETPharma
New Delhi: The Delhi High Court on Tuesday asked Sun Pharma Laboratories to take its prior approval before…
Amazon Is Bringing the Weight-Loss Drug Race to Medicare
This article first appeared on GuruFocus. Amazon.com Inc. (AMZN, Financials), the e-commerce and cloud-computing company, is expanding its…
Hairdressers selling ‘Ozempic’: SA’s wild weight loss market
A recent high-profile court judgment halting a Pretoria pharmacy from selling GLP-1 drugs at scale has seemingly done…
Lilly to file for next-gen obesity drug approval in early 2027
Investing.com — Eli Lilly announced Thursday it will file for approval of its next-generation obesity drug retatrutide in…
Does EU Approval of Wegovy Pill Change NVO’s Competitive Story?
Novo Nordisk NVO received a meaningful commercial boost last week after the European Commission approved the oral version of…
The data that led Cellular Intelligence to pick up Novo’s Parkinson’s stem cell therapy
MONTREAL — After Novo Nordisk closed its cell therapy unit, Cellular Intelligence contracted neurologist and drug developer Nuno…
2 Dirt Cheap Healthcare Stocks to Buy in July
Quick Read NVO trades at a forward P/E of 14 and PFE at just 8x, making both the…
Could This Healthcare Stock Help You Build a Real Fortune Over the Next 20 Years?
The short, but glib, answer to the headline question posed for Viking Therapeutics (NASDAQ: VKTX) investors is “no,”…
Canada approves generic version of Wegovy for weight loss
FILE – A dosage of Wegovy, March 1, 2024 in Front Royal, Va. (AP Photo/Amanda Andrade-Rhoades, File) –…
J&J CEO sends a clear message on the obesity drug boom
Johnson & Johnson (JNJ) just told Wall Street it will sit out the most lucrative drug race of…
Can Wegovy Pill’s Europe Push Help NVO Offset Mounting Pressures?
Last week, Novo Nordisk NVO secured a key regulatory win with the U.K. approval of the Wegovy pill…